Immunocore Holdings (IMCR) Other Non-Current Assets (2019 - 2026)

Immunocore Holdings (IMCR) has reported Other Non-Current Assets for 8 consecutive years, with $18.6 million the latest figure, recorded in Q1 2026.

• Quarterly Other Non-Current Assets rose 8.65% year-over-year to $18.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.6 million (up 8.65% YoY) and the FY2025 annual result came in at $20.3 million, up 18.49% from the prior year.
• Other Non-Current Assets declined to $18.6 million in Q1 2026 per IMCR's latest filing, from $20.3 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for IMCR reached as high as $20.3 million in Q4 2025 and fell as low as $8.0 million in Q3 2022.
• A 5-year average of $15.2 million and a median of $16.5 million in 2025 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2023 — Other Non-Current Assets surged 68.06% — and 2025, when it retreated 4.35%.
• Year by year, Other Non-Current Assets stood at $8.6 million in 2022, then jumped by 68.06% to $14.5 million in 2023, then grew by 18.27% to $17.1 million in 2024, then advanced by 18.49% to $20.3 million in 2025, then fell by 8.22% to $18.6 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $18.6 million, $20.3 million, and $16.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.